Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

Bristol-Myers Squibb (BMS) building

BMS shines in Q1, but Abilify generics cast a long shadow

Revenue up 6% but Ablify’s contribution likely to drop due to competition

- PMLiVE

Sanofi wins European approval for Lantus follow-up Toujeo

Long-acting insulin is a key part of the company's growth plans

- PMLiVE

Manjula Halai joins Wave Healthcare Communications

Moves to the med ed agency from the Royal Pharmaceutical Society

- PMLiVE

Terrence Higgins Trust pushes for HPV vaccine for men

Charity speaks out to coincide with European Immunisation Week

- PMLiVE

BioSure UK’s home HIV test goes on sale in the UK

Test delivers a diagnosis in just 15 minutes

- PMLiVE

Virgo Consumer Health & Wellbeing hires Kirsty McKinnon

Med comms agency strengthens senior team with new personal care sector lead

- PMLiVE

BIA says action plan could quadruple R&D output by 2025

Claims it could rank the UK in the global top three largest biotech clusters

- PMLiVE

Mylan pulls no punches in rejecting Teva takeover

Firm calls Israeli generics giant’s credibility into question

Sanofi reception

Sanofi gains accelerated review for rare disease drug

New pill for Fabry disease could be approved by the FDA before the end of the year

- PMLiVE

apceth names Ulrike Verzetnitsch as chief technical officer

She joins from Takeda, with immediate effect

- PMLiVE

Payment to docs rules ‘an opportunity for pharma’

The industry’s reputation can be boosted by openness, say pharma compliance leaders

Celgene building

Celgene to acquire biotech firm Quanticel Pharmaceuticals

Firm hopes to expand its pipeline of life-enhancing products for cancer patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links